Tag: FBN1 and PAX6 Genes
CRISPR-Cas9 Gene Editing Approved Gene Therapy for Permanent Diabetic Retinopathy Cell...
Diabetic Retinopathy (DR) is a serious eye condition and a leading cause of vision loss among individuals with diabetes. Traditional treatments, such as laser...
CRISPR Gene Editing for Pathogenic Myopia: Targeting Key Genes in FBN1...
Pathogenic myopia, a severe form of nearsightedness, poses significant challenges to individuals worldwide, often leading to irreversible vision impairment and increasing the risk of...
